MDMXF (Medmix AG) DeferredTaxAndRevenue: $0.0 Mil (As of Dec. 2025)


MDMXF Medmix AG MDMXF
61 GF Score
Price $17.40
GF Value $26.13
! 7 Warning Signs
View Full Analysis

What is Medmix AG DeferredTaxAndRevenue?

Medmix AG MDMXF 61 DeferredTaxAndRevenue is $0.0 Mil as of Dec. 2025. GuruFocus rates MDMXF with a GF Score™ of 61/100 and a GF Value™ of $26.13. The stock has 7 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Medmix AG's current deferred tax and revenue for the quarter that ended in Dec. 2025 was $0.0 Mil.

Medmix AG DeferredTaxAndRevenue Related Terms

Medmix AG DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Medmix AG's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG DeferredTaxAndRevenue Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MDMXF
61GF Score
Medmix AG MDMXF
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.0 Mil mean?
Medmix AG (MDMXF) has a DeferredTaxAndRevenue of $0.0 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Medmix AG.
Is Medmix AG's DeferredTaxAndRevenue too high?
Medmix AG's current DeferredTaxAndRevenue is $0.0 Mil. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's DeferredTaxAndRevenue compare to GEV and ETN?
Medmix AG's DeferredTaxAndRevenue of $0.0 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for an Industrial Products company?
A good DeferredTaxAndRevenue depends on the Industrial Products industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Medmix AG. Medmix AG's current DeferredTaxAndRevenue is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current DeferredTaxAndRevenue of $0.0 Mil. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current DeferredTaxAndRevenue is $0.0 Mil. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Medmix AG (MDMXF), the current DeferredTaxAndRevenue is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medmix AG (MDMXF) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued. The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.

Key valuation signals for MDMXF:

  • DeferredTaxAndRevenue: $0.0 Mil
  • GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medmix AG Business Description

Other Exchanges MEDXz:UKMEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score

Get the complete analysis for MDMXF

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.40
Price
$26.13
GF Value